IXICO (LON:IXI – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX (1.21) earnings per share for the quarter, Digital Look Earnings reports. IXICO had a negative net margin of 25.27% and a negative return on equity of 13.74%. The business had revenue of GBX 395 million for the quarter.
IXICO Stock Performance
IXICO stock opened at GBX 8 on Wednesday. IXICO has a 52 week low of GBX 6.26 and a 52 week high of GBX 15. The company has a current ratio of 3.03, a quick ratio of 4.90 and a debt-to-equity ratio of 1.53. The stock has a market cap of £17.44 million, a P/E ratio of -4.32, a price-to-earnings-growth ratio of -0.38 and a beta of 0.07. The stock has a 50 day moving average of GBX 7.37 and a 200-day moving average of GBX 9.47.
About IXICO
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
